Rate My Professor Christopher Gordon

Gordon directs a multidisciplinary team exploring the pathophysiological underpinnings of insomnia, including electroencephalographic slow wave dissipation, skin temperature-sleep-vigilance relationships, wearable-based sleep disturbance prediction, digital sleep health interventions for insomnia and cognitive decline, and lighting interventions to enhance sleep and cognition. He has established Australia's largest insomnia database, featuring extensive clinical, psychophysiological, and treatment data. His contributions include randomized controlled trials of digital therapeutics and non-pharmacological chronotherapies for circadian disruptions, alongside fostering industry-academic collaborations. Notable awards encompass the Australian Awards for University Teaching in 2017, Award for Excellence in Teaching in 2018, and Vice-Chancellor's Award in 2016. Gordon's publication record exceeds 105 peer-reviewed articles and 147 research outputs, with over 4,700 citations. Key works include 'Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial' (2026), 'Digital Cognitive Behavioural Therapy for Insomnia Compared to Sleep Health Education in Older Adults With Mild Cognitive Impairment and Insomnia: A Feasibility Randomised Controlled Trial' (2026), 'Is Metabolic Rate Increased in Insomnia Disorder? A Systematic Review' (2018), and 'Light-based methods for predicting circadian phase in delayed sleep-wake phase disorder' (2021). His research significantly impacts sleep health management and therapeutic innovation.